Nicolas Larmonier - Concepedia

Author

Nicolas Larmonier

University of Arizona ORCID

Also Known As

Billerey-Larmonier, Claire, Larmonier, Nicolas, N Larmonier, N. Larmonier, Nicolas Larmonier

106

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

University of Arizona Inserm Centre National de la Recherche Scientifique Université de Bourgogne Université de Bordeaux

About

Nicolas Larmonier is an author at University of Arizona specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.9K
2	Cell Biology	11	11	1.4K
3	Health Sciences	3	3	154
4	Biochemistry	2	2	127
5	Public Health	1	1	16

Nicolas Larmonier

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative François Ghiringhelli, Nicolas Larmonier, E. Schmitt, European Journal of Immunology T-regulatory CellImmunologyImmune RegulationImmunoeditingRegulatory T Cells	2004	862
Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer Darya Alizadeh, Malika Trad, Neale T. Hanke, Cancer Research	2013	398
CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease Xinchun Chen, Boping Zhou, Mei-zhong Li, Clinical Immunology Autoimmune DiseaseT-regulatory CellImmunologyRegulatory T CellsAutoimmunity	2007	276
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis Maxime Samson, Sylvain Audia, Jennifer Fraszczak, Arthritis & Rheumatism	2012	226
Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF-β and IL-10 Nicolas Larmonier, Marilyn Marron, Yi Zeng, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceT-regulatory CellImmunologyImmune RegulationTumor Immunity	2006	223
Imatinib Mesylate Inhibits CD4+CD25+ Regulatory T Cell Activity and Enhances Active Immunotherapy against BCR-ABL− Tumors Nicolas Larmonier, Nona Janikashvili, Collin J. LaCasse, The Journal of Immunology	2008	159
IFNγ Is Critical for CAR T Cell–Mediated Myeloid Activation and Induction of Endogenous Immunity Darya Alizadeh, Robyn A. Wong, Sharareh Gholamin, Cancer Discovery	2021	155
Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes Sylvain Audia, Alexandra Nicolas, Dominique Cathelin, Clinical & Experimental Immunology	2007	117
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia Sylvain Audia, M. Samson, Julien Guy, Blood	2011	112
Modulation of neutrophil motility by curcumin Claire B. Larmonier, Monica T. Midura‐Kiela, Rajesh Kumar Ramalingam, Inflammatory Bowel Diseases	2010	97

Page 1